Detail akcie Affluent Med online

Business Summary: Carvolix is a France-based company. The Company is engaged in developing Artificial Intelligence (AI)-driven autonomous mini-robots and biomimetic implants for interventional cardiology and stroke treatment. It operates through the consolidation, Caranx Medical, and Artedrone, and focuses on technologies used in cardiac valve replacement, structural heart interventions, and neurovascular procedures. It develops systems combining micro-robotics, artificial intelligence, imaging guidance, and implantable heart devices. Its product portfolio includes the TAVIPILOT software for transcatheter aortic valve implantation (TAVI), structural heart devices such as Kalios and Epygon, the Artus artificial urinary sphincter, and a robotic platform intended for stroke treatment.
Financial Summary: BRIEF: For the six months ended 30 June 2026, Carvolix SA revenues was not reported. Net loss increased 48% to EUR13.9M. Higher net loss reflects Labor & Related Expenses Other increase of 37% to EUR5.2M (expense), Depreciation and amortization increase of 95% to EUR2.3M (expense), Other External Services - Balancing val increase of 36% to EUR3.6M (expense).